Laura Indolfi: Good news in the fight against pancreatic cancer
Laura Indolfi: Gode nyheder i kampen mod bugspytkirtelkræft
Laura Indolfi is revolutionizing cancer treatment with new technologies including implantable devices for delivering drugs locally to the site of a tumor. Full bio
Double-click the English transcript below to play the video.
at least one person on the screen?
på skærmen.
in their fields.
inden for deres områder.
all of them have in common?
har til fælles?
very sad this news,
personlige historier
of how lethal this disease can be.
på hvor dødelig denne sygdom kan være.
of cancer deaths,
dødelige cancer,
will survive beyond five years.
vil overleve mere end fem år.
with breast cancer,
med brystkræft,
is almost 90 percent.
with pancreatic cancer
med kræft i bugspytskirtlen
certain death sentence.
en dødsdom.
is that in the last 40 years,
treatment more effective?
behandlingen af kræft i bugspytskirtlen?
that seem impossible,
problemer der virker umulige,
innovative solutions
nye innovative løsninger
with pancreatic cancer
angående kræft i bugspytskirtlen
of your belly, literally.
i midten af maven, bogstaveligt talt.
organs in front.
der ligger foran.
by many other vital organs,
vitale organer,
the bile duct.
galdegangen.
to grow into those organs
til disse organer
also prevents the doctor
gør det også umuligt for læger
for breast cancer, for example.
ved brystkræft, for eksempel.
chemotherapy as the only option
at kemoterapi er den eneste løsning
piece of bad news.
dårlige nyhed.
very few blood vessels.
blodårer.
about the blood vessel of a tumor?
hvor mange blodårer en tumor har?
how chemotherapy works.
at tænke over hvordan kemoterapi virker.
ind i blodåren
until it reaches the tumor site.
indtil det rammer tumoren.
trying to reach a destination.
og skulle finde en bestemt destination.
doesn't have an exit on the highway?
ikke har en afkørsel på motorvejen?
med bugspytskirtelkræft.
throughout all of your body.
hele kroppen.
for the patients overall,
for patienten, alt i alt
to have a whole-body treatment
at behandle hele kroppen
and effort have gone towards
og anstrengelser, på
to treat pancreatic cancer,
til behandling af bugspytskirtelkræft,
in changing the way
for at ændre måden hvorpå
good news, hopefully.
god nyhed, forhåbentlig.
General Hospital in Boston,
the way we treat cancer
hvorpå vi behandler kræft
drug delivery a reality.
til virkelighed.
on top of your destination,
ankomme til din destination via faldskærm,
all around the highway.
køre rundt og rundt på motorvejen.
into devices that look like this one.
i enheder som denne.
that they can be folded
til at kunne foldes
directly on top of the tumor
præcist lige ovenpå tumoren
that once they are positioned
så når de først er placeret
physically prevent the tumor
for at tumoren
slowly and more effectively
langsommere og mere effektivt
whole-body treatment.
behandling af hele kroppen.
we have demonstrated
har vi demonstreret
the response to treatment.
til behandling med 12 gange.
where it's needed the most,
hvor det er mest behøvet
that is 12 times more powerful,
mere effektiv,
this technology to the next level.
teknologien endnu bedre.
prækliniske tests
prior to asking the FDA for approval
før man kan anmode FDA om godkendelse
will die from pancreatic cancer.
dø af kræft i bugspytskirtlen.
extend their life
forlænge deres liv
more powerful and less toxic,
og mindre giftigt,
to finding new innovative solutions
nye inovative løsninger
umulige problemstillinger
ABOUT THE SPEAKER
Laura Indolfi - Biomedical entrepreneurLaura Indolfi is revolutionizing cancer treatment with new technologies including implantable devices for delivering drugs locally to the site of a tumor.
Why you should listen
Laura Indolfi is a biomedical entrepreneur, CEO and co-founder of PanTher Therapeutics, an early stage spin-out from MIT and MGH that provides superior technologies for revolutionizing the treatment of locally advanced inoperable solid tumors. Prior to this she served as an entrepreneur-in-residence at the MGH Cancer Center and as a research associate in the Harvard-MIT Institute for Medical Engineering and Science. She was selected as a TED Fellow in 2016.
Indolfi has broad professional experiences and interests ranging from biomedical engineering to entrepreneurship and outreaching initiative to promoting science. Her scientific expertise covers a broad range of therapeutic areas (cardio, cancer, inflammation, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Together with her strong technical background, Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business Schools and with several consulting firms. She strongly believes in the power of outreach initiatives to promote research awareness and foster the public audience's discovery of the beauty of science. In 2014 the line of clothes Cytocouture, created in collaboration with Colombian designer Carlos Villamil and inspired by her cell-therapy research, won the global competition Descience.
Indolfi holds a MS/BS degree in materials science and engineering and a PhD in biomaterials from the University of Naples Federico II in Italy. Upon graduation, she joined the Harvard-MIT Division of health, science and technology, working on several projects spanning from devices for local drug delivery to tissue engineering approaches for cell therapies.
Laura Indolfi | Speaker | TED.com